Disclosure Of First-Time Adoption [Text Block]

GenSight Biologics S.A. - Filing #2813015

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
15,279,000 EUR
170,024,000 EUR
27,625,000 EUR
181,211,000 EUR
1,158,000 EUR
28,617,000 EUR
15,989,000 EUR
137,726,000 EUR
181,175,000 EUR
1,158,000 EUR
1,022,000 EUR
34,015,000 EUR
108,034,000 EUR
152,776,000 EUR
11,749,000 EUR
Comprehensive income
27,748,000 EUR
124,000 EUR
27,625,000 EUR
207,000 EUR
28,617,000 EUR
28,824,000 EUR
Profit (loss)
27,625,000 EUR
27,625,000 EUR
28,617,000 EUR
28,617,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.